Vaccination

Throughout the course of human history, one infectious disease (Figure 1) may account for more deaths than any other, perhaps all others combined.

The risk for developing long COVID declined over the course of the pandemic but has remained significant, researchers reported.

Ivory Coast administered the first doses of the world’s second malaria vaccine this week, according to the vaccine’s manufacturers, marking the latest development in a decades-long effort to control the deadly mosquito-borne disease.

About 40% of cancer cases and nearly half of cancer deaths among U.S. adults aged 30 years or older can be attributable to modifiable risk factors, according to a study led by American Cancer Society researchers.

As health care workers, we have daily encounters with sick patients who could potentially have a contagious illness. Measles is a particular challenge in the health care setting.

Rather than telling a patient they should get a vaccine, the CDC’s shared clinical decision-making recommendations advise patients to speak to providers about certain vaccines and decide on an individual basis if they should receive them. 

HHS announced that it will give Moderna around $176 million to accelerate the development of a messenger RNA-based pandemic influenza vaccine amid an ongoing outbreak of avian influenza.

After decades of RSV vaccine development, the approvals and recommendations were seen as landmark events in preventive medicine. Uptake was low, however — not unusual for first-year approvals, experts told Healio.

The CDC on Thursday recommended updated COVID-19 vaccines for the 2024-2025 respiratory season, and a newly approved 21-valent pneumococcal conjugate vaccine for adults.

Together, a group of viruses nicknamed “FLiRT” have emerged to become the most common SARS-CoV-2 variants in the country.